OTREXUP, OTREXUP PFS: FDA Approved Drugs and User Comments
' + "
";
evCat = 'adx-impl';
evLabel = '/21865806531/yl-xk/336*280-01-wap-xk-yl';
} else {
html = "
" + '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/728*90-01-pc-xk-yl", [728, 90], "div-gpt-ad-1576640512222-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640512222-0")});
' + "
";
evCat = 'adx-impl';
evLabel = '/21865806531/yl-xk/728*90-01-pc-xk-yl';
}
var html2 = replaceAll2(html, "script2", "script");
fillHtml += randomAdxSlotId(html2);
_pf_event(evCat, PAGE_CAT, evLabel);
_pf_log("ga adsense single");
}
document.write(fillHtml);
}
showAd();
})();
Drug Name |
Active Ingredients |
Strength |
Dosage Form/Route |
Marketing Status |
OTREXUP |
METHOTREXATE |
10MG/0.4ML (10MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
15MG/0.4ML (15MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
20MG/0.4ML (20MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
25MG/0.4ML (25MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
7.5MG/0.4ML (7.5MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP |
METHOTREXATE |
12.5MG/0.4ML (12.5MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
17.5MG/0.4ML (17.5MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP |
METHOTREXATE |
22.5MG/0.4ML (22.5MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Prescription |
OTREXUP PFS |
METHOTREXATE |
10MG/0.4ML (10MG/0.4ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP PFS |
METHOTREXATE |
15MG/0.6ML (15MG/0.6ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP PFS |
METHOTREXATE |
17.5MG/0.7ML (17.5MG/0.7ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP PFS |
METHOTREXATE |
20MG/0.8ML (20MG/0.8ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP PFS |
METHOTREXATE |
22.5MG/0.9ML (22.5MG/0.9ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
OTREXUP PFS |
METHOTREXATE |
25MG/ML (25MG/ML) |
SOLUTION;SUBCUTANEOUS |
Discontinued |
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
";
}
function showAd(){
var s = getQueryStringByName('s');
var isSearchPage = (s != '');
var isMobile = /iPhone|iPad|iPod|Android/i.test(navigator.userAgent);
var html = '';
var html2 = '';
if (isSearchPage) {
if (isMobile) {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-01-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640284306-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640284306-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-01-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-02-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640310637-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640310637-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-02-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-03-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640337768-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640337768-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-03-wap-n-xk-yl');
} else {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-pc-n-xk-yl", [300, 600], "div-gpt-ad-1576640117816-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640117816-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-pc-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-02-pc-n-xk-yl", [300, 600], "div-gpt-ad-1576640172416-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640172416-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-02-pc-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
}
} else {
if (isMobile) {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-04-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640363074-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640363074-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-04-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-05-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640388002-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640388002-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-05-wap-n-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/336x280-06-wap-n-xk-yl", [336, 280], "div-gpt-ad-1576640412938-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576640412938-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/336x280-06-wap-n-xk-yl');
} else {
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x250-01-healthtopquestions-xk-yl", [300, 250], "div-gpt-ad-1576639270555-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639270555-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x250-01-healthtopquestions-xk-yl');
html2 = '
googletag.cmd.push(function() {googletag.defineSlot("/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl", [300, 600], "div-gpt-ad-1576639775063-0").addService(googletag.pubads());googletag.pubads().enableSingleRequest();googletag.enableServices()});googletag.cmd.push(function() {googletag.display("div-gpt-ad-1576639775063-0")});
'; html2 = randomAdxSlotId(html2);
html += html2;
_pf_event('adx-impl', PAGE_CAT, '/21865806531/yl-xk/300x600-01-healthtopquestions-xk-yl');
}
}
var html2 = replaceAll2(html, 'script2', 'script');
document.write(html2);
}
showAd();
})();
User Comments:
For Rheumatoid Arthritis “I was in remission with Arava and oral methotrexate for 7 years, but stopped taking methotrexate because I didn’t think I needed it anymore and I was slightly nauseated every time I took it. It was a big mistake because my feet are a hot mess. I became totally out of remission with major shoulder/neck pain and fatigue. I recently added Otrexup, in additional taking Arava. After 2 weeks I was pain free and my energy level has returned. I am paying $179 per month for Otrexup and it’s a hardship. I am planning to discuss with my doctor going back on oral methotrexate which is only $10 per month.”
karkeeki October 16, 2016